---
title: "Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment | ACHV Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286952863.md"
description: "Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment | ACHV Stock News"
datetime: "2026-05-19T10:15:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286952863.md)
  - [en](https://longbridge.com/en/news/286952863.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286952863.md)
---

# Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment | ACHV Stock News

Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment | ACHV Stock News

### Related Stocks

- [ACHV.US](https://longbridge.com/en/quote/ACHV.US.md)

## Related News & Research

- [Achieve Life Sciences Adds Director Amid Board Transitions](https://longbridge.com/en/news/286099106.md)
- [Achieve Life Sciences Announces Up to $354 Million Private Placement | ACHV Stock News](https://longbridge.com/en/news/283004765.md)
- [Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 | WVE Stock News](https://longbridge.com/en/news/286925108.md)
- [16:52 ETNexusTek Named a Contender in ISG Provider Lens® Life Sciences Digital Services 2026 Report](https://longbridge.com/en/news/286818120.md)
- [Jacobs Growth Could Improve on Data Centers, Life Sciences Demand, RBC Says](https://longbridge.com/en/news/286945689.md)